M. Zuluaga

Combination of photodynamic therapy with anti-cancer agents.

N. Lange, M. Zuluaga, María-Fernanda Zuluaga, 2008, Current medicinal chemistry.

Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system.

C. Gabay, E. Allémann, E. Doelker, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.

R. Gurny, C. Mailhos, D. Shima, 2007, Investigative ophthalmology & visual science.

Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis.

R. Gurny, N. Lange, M. Zuluaga, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Urokinase-plasminogen-activator sensitive polymeric photosensitizer prodrugs: design, synthesis and in vitro evaluation

N. Lange, M. Campo, M. Zuluaga, 2009 .

Physicochemical Characterization and Application of Yam (Dioscorea cayenensis‐rotundata) Starch as a Pharmaceutical Excipient

Yolima Baena, M. Zuluaga, Claudia Mora, 2007 .

Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs.

Norbert Lange, N. Lange, M. Zuluaga, 2012, Molecular pharmaceutics.

Selective Photodetection and Photodynamic Therapy for Prostate Cancer through Targeting of Proteolytic Activity

N. Lange, N. Sekkat, M. Zuluaga, 2012, Molecular Cancer Therapeutics.

On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds

N. Lange, M. Zuluaga, D. Gabriel, 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.